Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michelle Ghert, MD, FRCSC
McMaster University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
54 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario Austral
Pilar, Buenos Aires, Argentina
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Lkh - Universitätsklinikum Graz
Graz, Austria
- Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil
- Instituto de Ortopedia E Traumatologia
São Paulo, Brazil
- Foothills Medical Centre
Calgary, Alberta, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Juravinski Hospital and Cancer Centre
Hamilton, Ontario, Canada
- Ottawa Hospital
Ottawa, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
- Hôtel-Dieu de Québec
Québec, Quebec, Canada
- Children'S Cancer Hospital Egypt
Cairo, Egypt
- All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
- Leiden University Medical Center
Leiden, South Holland, Netherlands
- University Medical Center Groningen
Groningen, Netherlands
- Singapore General Hospital
Singapore, Singapore
- Grey'S Hospital
Pietermaritzburg, South Africa
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- Stanford University Hospital and Clinics
Redwood City, California, United States
- Uc Davis Comprehensive Cancer Center
Sacramento, California, United States
- University of California San Francisco Medical Center
San Francisco, California, United States
- University of Connecticut Health Center
Farmington, Connecticut, United States
- Hartford Hospital
Hartford, Connecticut, United States
- University of Florida Health Shands Hospital
Gainesville, Florida, United States
- Emory Orthopaedics and Spine Center
Atlanta, Georgia, United States
- Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Franklin Square Medical Center
Baltimore, Maryland, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Sinai Hospital of Baltimore
Baltimore, Maryland, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Minnesota Medical Center
Minneapolis, Minnesota, United States
- Saint Louis University Hospital
St Louis, Missouri, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2013
- Primary completion
- 31 Mar 2021
- Completion
- 31 Mar 2021
- Last update posted
- 11 Mar 2021
- Registered enrollment
- 602
- Registry id
- NCT01479283
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.